Display options
Share it on

Vet Med Sci. 2016 Dec 16;3(1):3-12. doi: 10.1002/vms3.51. eCollection 2017 Feb.

Using oral fluids samples for indirect influenza A virus surveillance in farmed UK pigs.

Veterinary medicine and science

Priscilla F Gerber, Lorna Dawson, Ben Strugnell, Robert Burgess, Helen Brown, Tanja Opriessnig

Affiliations

  1. The Roslin Institute and The Royal (Dick) School of Veterinary StudiesUniversity of EdinburghMidlothianScotlandUK.
  2. School of AgricultureFood and Rural DevelopmentNewcastle UniversityNewcastle upon TyneUK.
  3. Evidence-based Veterinary Consultancy (EBVC) Ltd.Rural Enterprise CentreRedhillsPenrithCumbriaUK.
  4. Department of Veterinary Diagnostic and Production Animal MedicineIowa State UniversityAmesIowaUSA.

PMID: 29067204 PMCID: PMC5645835 DOI: 10.1002/vms3.51

Abstract

Influenza A virus (IAV) is economically important in pig production and has broad public health implications. In Europe, active IAV surveillance includes demonstration of antigen in nasal swabs and/or demonstration of antibodies in serum (SER) samples; however, collecting appropriate numbers of individual pig samples can be costly and labour-intensive. The objective of this study was to compare the probability of detecting IAV antibody positive populations using SER versus oral fluid (OF) samples. Paired pen samples, one OF and 5-14 SER samples, were collected cross-sectional or longitudinally. A commercial nucleoprotein (NP)-based blocking ELISA was used to test 244 OF and 1004 SER samples from 123 pens each containing 20-540 pigs located in 27 UK herds. Overall, the IAV antibody detection rate was higher in SER samples compared to OFs under the study conditions. Pig age had a significant effect on the probability of detecting positive pens. For 3-9-week-old pigs the probability of detecting IAV antibody positive samples in a pen with 95% confidence intervals was 40% (23-60) for OF and 61% (0.37-0.80) for SER (

Keywords: Swine influenza virus; diagnostics; enzyme‐linked immunosorbent assay; surveillance

References

  1. J Gen Virol. 2001 Nov;82(Pt 11):2697-707 - PubMed
  2. Transbound Emerg Dis. 2016 Oct;63(5):e328-38 - PubMed
  3. Vet Res. 2013 Sep 04;44:72 - PubMed
  4. Virus Res. 2015 Apr 2;201:24-31 - PubMed
  5. Vaccine. 2013 Dec 16;31(52):6210-5 - PubMed
  6. Transbound Emerg Dis. 2016 Feb;63(1):24-35 - PubMed
  7. J Vet Diagn Invest. 2013 May;25(3):328-35 - PubMed
  8. Clin Vaccine Immunol. 2015 Oct;22(10):1109-20 - PubMed
  9. Influenza Res Treat. 2011;2011:163745 - PubMed
  10. Zoonoses Public Health. 2014 Feb;61(1):4-17 - PubMed
  11. J Vet Diagn Invest. 2009 Jan;21(1):88-96 - PubMed
  12. Transbound Emerg Dis. 2014 Apr;61(2):177-84 - PubMed
  13. J Vet Diagn Invest. 2014 Mar;26(2):277-81 - PubMed
  14. Curr Top Microbiol Immunol. 2013;370:85-112 - PubMed
  15. Zoonoses Public Health. 2011 Mar;58(2):93-101 - PubMed
  16. Influenza Other Respir Viruses. 2016 Jul;10 (4):291-300 - PubMed
  17. PLoS Curr. 2011 Feb 11;3:RRN1209 - PubMed
  18. J Vet Diagn Invest. 2010 Jan;22(1):3-9 - PubMed
  19. Methods Mol Biol. 2008;436:19-26 - PubMed
  20. Zoonoses Public Health. 2009 Aug;56(6-7):310-25 - PubMed
  21. Curr Top Microbiol Immunol. 2014;385:307-26 - PubMed
  22. Vet Microbiol. 2013 Mar 23;162(2-4):543-50 - PubMed
  23. Epidemiol Infect. 2015 Jul;143(10):2187-204 - PubMed
  24. Vet J. 2012 Jul;193(1):180-4 - PubMed
  25. Vet Rec. 2012 Sep 15;171(11):271 - PubMed
  26. Emerg Infect Dis. 2013 Jun;19(6):954-60 - PubMed
  27. PLoS One. 2014 Dec 26;9(12):e115815 - PubMed
  28. Vet Res. 2012 Mar 27;43:24 - PubMed

Publication Types